|Monday, February 18, 2019|
|03:30 PM - 06:00 PM Eastern Standard Time|
The uncertainties looming over the Brexit have caused worries on the global economy and also the continuity of quality healthcare services. However, much less has been discussed on the implications of this momentous decision in the Asia-Pacific, especially regulatory authorities which reference the health product decisions made in the EU and UK.
Morgan Lewis consultant Paul Ranson will share his thoughts on the potential effects of Brexit on access to health products, how this may influence activities in the region, and what can be done to better prepare health systems against the impact.
More details can be found here.